Clinical Trials Logo

Recurrent Ventricular Tachycardia clinical trials

View clinical trials related to Recurrent Ventricular Tachycardia.

Filter by:
  • None
  • Page 1

NCT ID: NCT02799693 Recruiting - Clinical trials for Recurrent Ventricular Tachycardia

Intramural Needle Ablation for Ventricular Tachycardia

Start date: July 2016
Phase: N/A
Study type: Observational

This is a single-arm non-randomized prospective observational cohort study to assess the outcomes of patients undergoing intramural needle catheter ablation of recurrent ventricular tachycardia that has failed antiarrhythmic drug therapy and standard radiofrequency (RF) catheter ablation. Following ablation, patients will be monitored for 6 months. The duration of the study is up to 4 years.

NCT ID: NCT00905853 Completed - Clinical trials for Recurrent Ventricular Tachycardia

Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy

VANISH
Start date: May 2009
Phase: Phase 4
Study type: Interventional

This study will compare aggressive antiarrhythmic therapy to catheter ablation for ventricular tachycardia in patients who have suffered prior myocardial infarction. The purpose of this study is to evaluate the optimal management of patients presenting with recurrent VT and receiving ICD therapy in spite of first-line antiarrhythmic drug therapy. The hypothesis is catheter ablation is superior to aggressive antiarrhythmic drug therapy for recurrent VT.